← Back to Search

Behavioral Intervention

Mobile-enhanced Engagement Intervention for HIV

N/A

Waitlist Available

Led By Renata Sanders, MD, ScM, MPH

Research Sponsored by Johns Hopkins Bloomberg School of Public Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18-months

Awards & highlights

Study Summary

This trial will address HIV disparities among young black and latinx men who have sex with men, and transgender women, by providing a mobile-enhanced intervention to identify, engage, and retain high-risk HIV-uninfected and HIV-infected participants in the HIV prevention and treatment cascade.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HIV Viral Suppression

PrEP Uptake

Secondary outcome measures

Engagement in substance abuse treatment services

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mobile-enhanced Engagement InterventionExperimental Treatment1 Intervention

Mobile-enhanced engagement intervention (MEI) to support HIV-positive and high risk HIV-negative participants achieve sustained engagement and sustained retention in HIV treatment or HIV prevention (PrEP) and substance use services at 18-months.

Group II: Control - SOC Case ManagementActive Control1 Intervention

Standard of care (SOC) case management.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mobile-enhanced Engagement Intervention

2017

N/A

~640

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins Bloomberg School of Public HealthLead Sponsor

410 Previous Clinical Trials

2,106,299 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,469 Previous Clinical Trials

2,618,778 Total Patients Enrolled

Renata Sanders, MD, ScM, MPHPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health and JHU School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to participate in this experiment?

"Candidates for the medical trial must be between 15 and 24 years old, with a confirmed HIV-1 infection. The research team seeks to recruit 465 young people in total."

Answered by AI

Is the age criterion for this trial limited to individuals over fifty-five?

"This research study has a preset age range, with patients between 15 and 24 years old eligible for enrollment."

Answered by AI

Are recruitment efforts for this investigation ongoing?

"Clinicaltrials.gov states that this experiment is not currently enrolling patients, despite having been first posted on August 1st 2017 and subsequently edited on October 3rd 2022. However, there are over one hundred other medical trials actively searching for participants at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Providing Unique Support for Health (PUSH) Study

2017. "Providing Unique Support for Health (PUSH) Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03194477.